Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0684249 (
lung carcinoma
)
23,830
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Real-time quantitative polymerase chain reaction (QPCR) using the Roche LightCycler was used to verify the expression of
asparagine synthetase
(
ASNS
) identified by microarray analysis as a target of p53 transrepression and mutant p53 transactivation. A p53-null cell line derived from
lung carcinoma
, H1299, was infected with recombinant adenovirus expressing wild-type (WT) p53, mutant p53-D281G, or beta-galactosidase as a control. After 24 h of infection, RNA was harvested and used for microarray analysis.
ASNS
was one of several genes whose expression was down-regulated by WT p53 and up-regulated in the presence of mutant p53. Expression levels of
ASNS
were measured relative to an exogenously applied quality-control nucleic acid template. Real-time PCR product accumulation was monitored using the intercalating dye, SYBR Green I, which exhibits a higher fluorescence upon binding of double-stranded DNA. Relative gene expression was calculated using conditions at the early stages of PCR, when amplification was logarithmic and, thus, could be correlated to initial copy number of gene transcripts.
ASNS
was found to be down-regulated in the presence of WT p53 and up-regulated by mutant p53.
...
PMID:Real-time polymerase chain reaction quantitation of relative expression of genes modulated by p53 using SYBR Green I. 1282 26